In a Manhattan federal courtroom, Luigi Mangione confessed to the December 2024 killing of UnitedHealthcare CEO Brian Thompson, a shooting that transformed a corporate crime into a national referendum on healthcare, suffering, and the moral limits of grievance. Mangione, who cited years of pain and systemic frustration as his motivation, pleaded guilty to federal stalking charges after more serious counts were dismissed on legal technicalities. He now faces possible life imprisonment at sentencing in December, while state murder charges and a double jeopardy challenge keep the legal story unre
Mangione pleads guilty to stalking in UnitedHealthcare CEO killing
I shot Mr. Thompson in Manhattan and he died.
Why does a guilty plea in federal court matter if he's still facing state charges?
Because the federal case was the one with teeth. Murder and weapons charges carry the death penalty. Once those were dismissed on technicalities, the stalking charges became almost a legal formality—serious, but not capital. The state case is where the real fight happens now.
His lawyer says double jeopardy should wipe out the state charges. Is that realistic?
It's an argument, but it's not automatic. Double jeopardy protects you from being tried twice for the same offense, but prosecutors will argue these are different jurisdictions, different legal theories. Courts have let both proceed before. It depends on the judge.
What strikes you most about what he said in court?
That he traced it all back to his back pain and the insurance system. He didn't claim insanity or accident. He owned it completely, but he also explained it—this is what the system did to me, this is why. That's different from remorse, and it matters for how people interpret the case.
The U.S. attorney said there can be no celebrity in assassination. Do you think that's working?
No. The man shouting "America loves Luigi" as the family left court—that's the answer. You can't un-ring that bell. The case has become a referendum on healthcare, not just a murder trial. The sentence won't change that.
What happens in December?
Sentencing. The prosecutor wants life without parole. The defense will argue for something less, probably. The judge will decide. And then the state case moves forward, unless double jeopardy arguments succeed. This isn't over.
Der Puls
- A man who built his own weapon and planned his act with deliberation now stands convicted, yet the public remains sharply divided on whether he is a killer or a symbol.
- Federal murder charges collapsed on legal technicalities, stripping prosecutors of their most powerful tools and leaving only stalking counts that still carry the possibility of life without parole.
- The Manhattan U.S. attorney vowed to seek the maximum sentence, declaring that 'there can be no celebrity in assassination' — a direct challenge to the crowds cheering Mangione outside courthouses.
- His defense is now pressing a double jeopardy argument to have pending New York state murder charges dismissed, meaning the legal battle is far from over regardless of the federal outcome.
- Thompson's family called the plea a step toward justice while a stranger in the crowd shouted 'America loves Luigi' — two responses that together define the unresolved wound this case has opened.
In a Manhattan federal courtroom, Luigi Mangione confessed to the December 2024 killing of UnitedHealthcare CEO Brian Thompson, a shooting that transformed a corporate crime into a national referendum on healthcare, suffering, and the moral limits of grievance. Mangione, who cited years of pain and systemic frustration as his motivation, pleaded guilty to federal stalking charges after more serious counts were dismissed on legal technicalities. He now faces possible life imprisonment at sentencing in December, while state murder charges and a double jeopardy challenge keep the legal story unresolved. The case has forced a reckoning with a question societies rarely ask so openly: when institutions fail people profoundly enough, where does accountability end and violence begin?
Luigi Mangione stood before a Manhattan federal judge and admitted, in plain terms, that he shot Brian Thompson and that Thompson died. The confession resolved the federal portion of a case that had gripped the country since December 4, 2024, when Thompson — chief executive of UnitedHealthcare — was struck by three bullets in the back as he walked toward a Midtown hotel for his company's investor conference.
Mangione told the court that his actions grew from years of agonizing back pain and the relentless frustration of navigating a health insurance system that, in his telling, denied and delayed rather than helped. Thompson's company, he said, was the embodiment of that system. He also disclosed that he had used a 3D printer to manufacture part of the weapon — a detail that spoke to the deliberateness of the act.
The federal case had already been significantly narrowed. A judge earlier dismissed the murder and weapons charges on legal technicalities, removing the possibility of a death sentence. What remained were two stalking counts, and it was to those that Mangione pleaded guilty. Sentencing is set for December, and prosecutors have made clear they will seek life without parole. Manhattan's U.S. attorney put it bluntly: there can be no celebrity in assassination.
Yet the legal story does not end there. Mangione still faces state charges in New York — murder, weapons, and forgery counts — and his defense attorney argued outside the courthouse that those charges must be dismissed under double jeopardy protections. Whether a judge will agree remains unresolved.
Thompson's family called the plea an important step toward justice and asked the court to impose a sentence matching the gravity of the crime. As they departed in a convoy of black SUVs, a voice from the crowd called out in Mangione's support. The division the case had always carried — between those who see a murderer and those who see a man broken by a broken system — showed no sign of closing.
Luigi Mangione stood in a Manhattan federal courtroom and confessed to the killing that had consumed the nation's attention for months. "I shot Mr. Thompson in Manhattan and he died," he told the judge, his words cutting through the procedural machinery with stark simplicity. The plea resolved what remained of the federal case against him—two counts of stalking tied to the December 4, 2024 shooting death of Brian Thompson, chief executive of UnitedHealthcare, one of America's largest health insurers.
Thompson had been walking into a Midtown Manhattan hotel that morning, headed to his company's annual investor conference, when Mangione fired three shots into his back. The killing had ignited a fierce national argument about healthcare, corporate accountability, and the limits of public sympathy for violence. Some saw Mangione as a symbol of justified rage against a broken system; others, including President Donald Trump, demanded severe punishment. The courtroom plea marked a turning point in the legal machinery, though not necessarily an ending.
Mangione explained his actions to the court by reaching back into his own suffering. He had endured years of severe pain from a broken back, he said, and had spent that time navigating the obstacles of the health insurance system—the denials, the delays, the bureaucratic walls that stood between him and relief. Thompson's company was the embodiment of that system. Mangione also revealed that he had used a 3D printer to manufacture part of the gun used in the shooting, a detail that underscored the deliberation behind the act.
The federal case had already been stripped of its most serious charges. Earlier in the year, a judge had dismissed the murder and weapons counts on legal technicalities, eliminating the possibility of a death sentence and leaving only the stalking charges. Now, with the guilty plea accepted, sentencing was scheduled for December. Mangione faced a possible sentence of life without parole on the two stalking counts. Jamie McDonald, the Manhattan U.S. attorney, told reporters his office would seek exactly that: life imprisonment. "There can be no celebrity in assassination," he said, a direct rebuke to the supporters who had gathered outside courthouses and shouted their approval.
But the federal case was only part of the legal landscape. Mangione still faced separate charges in New York state court—murder, weapons, and forgery counts that carried their own weight and their own potential consequences. His defense lawyer, Karen Friedman Agnifilo, argued outside the courthouse that those state charges must be dismissed under New York's double jeopardy protections, which shield defendants from being prosecuted twice for the same crime. Whether a judge would agree remained an open question.
Thompson's family released a statement calling the plea "an important step toward justice." They urged the court to ensure that sentencing would reflect what they saw as the severity of the crime. As they left the courthouse Friday in a convoy of black SUVs, a man shouted from the crowd: "America loves Luigi." The division that had marked the case from the beginning—between those who saw Mangione as a victim of a predatory system and those who saw him as a murderer—remained unresolved, waiting for December and whatever sentence the judge would impose.
Bemerkenswerte Zitate
There can be no celebrity in assassination.— Jamie McDonald, Manhattan U.S. attorney
State charges must be dismissed under New York's double jeopardy protections.— Karen Friedman Agnifilo, Mangione's defense lawyer